Maccura Historical Balance Sheet

300463 Stock

14.20 0.17 1.21%

Trend analysis of Maccura Biotechnology Co balance sheet accounts such as Other Current Liab of 9.5 M, Total Current Liabilities of 1.1 B or Total Stockholder Equity of 3.8 B provides information on Maccura Biotechnology's total assets, liabilities, and equity, which is the actual value of Maccura Biotechnology to its prevalent stockholders. By breaking down trends over time using Maccura Biotechnology balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Maccura Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Maccura Biotechnology is a good buy for the upcoming year.

Maccura Biotechnology Inventory

775.14 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Maccura Biotechnology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Maccura Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Maccura Biotechnology at a specified time, usually calculated after every quarter, six months, or one year. Maccura Biotechnology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Maccura Biotechnology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Maccura currently owns. An asset can also be divided into two categories, current and non-current.

Maccura Biotechnology Balance Sheet Chart

At present, Maccura Biotechnology's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Other Liabilities is expected to grow to about 299.5 M, whereas Total Assets are forecasted to decline to about 5.4 B.

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Short Term Debt Good Will

Total Assets

Total assets refers to the total amount of Maccura Biotechnology assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Maccura Biotechnology books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Maccura Biotechnology balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Maccura Biotechnology Co are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Good Will

An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.

Most accounts from Maccura Biotechnology's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Maccura Biotechnology current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Maccura Biotechnology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	189.9M	171.5M	10.0M	9.5M
Total Assets	6.6B	8.2B	8.1B	5.4B

Other Current Liab Total Assets

Maccura Biotechnology balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Short Term Investments	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.34	0.81	0.98	0.91	0.98	0.97	0.96	0.94	0.71	0.95	0.96	0.84	0.86	0.92	0.88	0.99	0.9	-0.14	0.94	0.86	0.46	0.98	0.94	0.95	-0.89
Other Current Liab	0.34		0.59	0.19	0.23	0.36	0.48	0.3	0.24	0.71	0.5	0.53	0.61	0.63	0.09	0.23	0.27	0.11	0.57	0.31	0.0	0.69	0.43	0.32	0.19	-0.39
Total Current Liabilities	0.81	0.59		0.67	0.73	0.75	0.86	0.79	0.79	0.75	0.94	0.91	0.9	0.99	0.71	0.79	0.75	0.54	0.03	0.84	0.71	0.86	0.83	0.9	0.67	-0.9
Total Stockholder Equity	0.98	0.19	0.67		0.88	0.97	0.92	0.92	0.9	0.6	0.87	0.89	0.74	0.73	0.92	0.86	0.98	0.95	-0.22	0.9	0.85	0.28	0.93	0.87	0.96	-0.8
Other Liab	0.91	0.23	0.73	0.88		0.93	0.91	0.91	0.99	0.75	0.85	0.89	0.69	0.8	0.96	0.72	0.89	0.85	-0.1	0.84	0.78	0.28	0.93	0.92	0.93	-0.79
Retained Earnings	0.98	0.36	0.75	0.97	0.93		0.96	0.95	0.94	0.76	0.92	0.95	0.78	0.82	0.92	0.82	0.98	0.93	-0.08	0.92	0.8	0.37	0.97	0.91	0.97	-0.84
Accounts Payable	0.97	0.48	0.86	0.92	0.91	0.96		0.95	0.94	0.78	0.96	0.98	0.85	0.91	0.89	0.83	0.95	0.85	-0.02	0.9	0.79	0.53	0.98	0.93	0.92	-0.87
Cash	0.96	0.3	0.79	0.92	0.91	0.95	0.95		0.93	0.71	0.89	0.92	0.72	0.84	0.9	0.81	0.96	0.9	-0.14	0.91	0.85	0.43	0.94	0.93	0.95	-0.87
Other Assets	0.94	0.24	0.79	0.9	0.99	0.94	0.94	0.93		0.75	0.9	0.92	0.76	0.84	0.98	0.8	0.91	0.85	-0.16	0.88	0.84	0.36	0.95	0.97	0.93	-0.86
Long Term Debt	0.71	0.71	0.75	0.6	0.75	0.76	0.78	0.71	0.75		0.79	0.84	0.77	0.83	0.64	0.57	0.65	0.51	0.26	0.66	0.47	0.52	0.77	0.75	0.64	-0.71
Net Receivables	0.95	0.5	0.94	0.87	0.85	0.92	0.96	0.89	0.9	0.79		0.99	0.94	0.96	0.86	0.89	0.91	0.75	-0.06	0.93	0.81	0.68	0.95	0.95	0.84	-0.94
Inventory	0.96	0.53	0.91	0.89	0.89	0.95	0.98	0.92	0.92	0.84	0.99		0.92	0.95	0.87	0.87	0.92	0.78	-0.05	0.91	0.8	0.62	0.96	0.95	0.87	-0.93
Other Current Assets	0.84	0.61	0.9	0.74	0.69	0.78	0.85	0.72	0.76	0.77	0.94	0.92		0.9	0.72	0.83	0.75	0.55	-0.05	0.78	0.68	0.74	0.84	0.85	0.66	-0.9
Total Liab	0.86	0.63	0.99	0.73	0.8	0.82	0.91	0.84	0.84	0.83	0.96	0.95	0.9		0.75	0.77	0.8	0.61	0.08	0.86	0.7	0.79	0.89	0.92	0.74	-0.91
Intangible Assets	0.92	0.09	0.71	0.92	0.96	0.92	0.89	0.9	0.98	0.64	0.86	0.87	0.72	0.75		0.81	0.91	0.87	-0.26	0.88	0.88	0.26	0.92	0.94	0.94	-0.83
Common Stock	0.88	0.23	0.79	0.86	0.72	0.82	0.83	0.81	0.8	0.57	0.89	0.87	0.83	0.77	0.81		0.87	0.72	-0.44	0.85	0.94	0.55	0.8	0.85	0.76	-0.87
Property Plant Equipment	0.99	0.27	0.75	0.98	0.89	0.98	0.95	0.96	0.91	0.65	0.91	0.92	0.75	0.8	0.91	0.87		0.95	-0.17	0.95	0.87	0.39	0.96	0.9	0.97	-0.85
Net Tangible Assets	0.9	0.11	0.54	0.95	0.85	0.93	0.85	0.9	0.85	0.51	0.75	0.78	0.55	0.61	0.87	0.72	0.95		-0.16	0.85	0.77	0.12	0.88	0.78	0.98	-0.68
Short Term Investments	-0.14	0.57	0.03	-0.22	-0.1	-0.08	-0.02	-0.14	-0.16	0.26	-0.06	-0.05	-0.05	0.08	-0.26	-0.44	-0.17	-0.16		-0.06	-0.54	0.14	-0.01	-0.15	-0.13	0.25
Deferred Long Term Liab	0.94	0.31	0.84	0.9	0.84	0.92	0.9	0.91	0.88	0.66	0.93	0.91	0.78	0.86	0.88	0.85	0.95	0.85	-0.06		0.84	0.55	0.93	0.93	0.91	-0.87
Long Term Investments	0.86	0.0	0.71	0.85	0.78	0.8	0.79	0.85	0.84	0.47	0.81	0.8	0.68	0.7	0.88	0.94	0.87	0.77	-0.54	0.84		0.39	0.78	0.86	0.81	-0.83
Short Long Term Debt	0.46	0.69	0.86	0.28	0.28	0.37	0.53	0.43	0.36	0.52	0.68	0.62	0.74	0.79	0.26	0.55	0.39	0.12	0.14	0.55	0.39		0.47	0.56	0.24	-0.68
Total Current Assets	0.98	0.43	0.83	0.93	0.93	0.97	0.98	0.94	0.95	0.77	0.95	0.96	0.84	0.89	0.92	0.8	0.96	0.88	-0.01	0.93	0.78	0.47		0.95	0.95	-0.88
Short Term Debt	0.94	0.32	0.9	0.87	0.92	0.91	0.93	0.93	0.97	0.75	0.95	0.95	0.85	0.92	0.94	0.85	0.9	0.78	-0.15	0.93	0.86	0.56	0.95		0.89	-0.94
Non Current Assets Total	0.95	0.19	0.67	0.96	0.93	0.97	0.92	0.95	0.93	0.64	0.84	0.87	0.66	0.74	0.94	0.76	0.97	0.98	-0.13	0.91	0.81	0.24	0.95	0.89		-0.79
Non Currrent Assets Other	-0.89	-0.39	-0.9	-0.8	-0.79	-0.84	-0.87	-0.87	-0.86	-0.71	-0.94	-0.93	-0.9	-0.91	-0.83	-0.87	-0.85	-0.68	0.25	-0.87	-0.83	-0.68	-0.88	-0.94	-0.79

Click cells to compare fundamentals

Maccura Biotechnology Account Relationship Matchups

Maccura Biotechnology balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	5.5B	6.4B	6.6B	8.2B	8.1B	5.4B
Other Current Liab	155.7M	255.0M	189.9M	171.5M	10.0M	9.5M
Total Current Liabilities	1.8B	1.8B	1.3B	1.1B	1.1B	1.1B
Total Stockholder Equity	3.1B	3.8B	4.3B	6.3B	6.4B	3.8B
Other Liab	149.8M	231.9M	270.7M	248.0M	285.2M	299.5M
Retained Earnings	2.2B	2.9B	3.6B	4.0B	3.8B	2.5B
Accounts Payable	261.6M	402.1M	317.4M	380.9M	365.8M	244.9M
Cash	443.9M	612.1M	637.2M	587.3M	836.0M	487.8M
Other Assets	225.8M	327.2M	336.5M	342.8M	394.3M	414.0M
Long Term Debt	200M	329.7M	424.1M	285.8M	162.5M	240.5M
Net Receivables	2.0B	2.0B	1.9B	2.1B	1.8B	1.6B
Inventory	851.7M	1.1B	1.1B	1.0B	907.5M	775.1M
Other Current Assets	208.7M	235.8M	195.8M	251.9M	112.6M	175.1M
Total Liab	2.2B	2.4B	2.0B	1.6B	1.5B	1.5B
Intangible Assets	210.7M	245.6M	280.8M	374.5M	420.8M	441.8M
Common Stock	557.7M	557.1M	556.5M	612.5M	704.3M	524.6M
Property Plant Equipment	1.6B	1.7B	2.0B	2.5B	2.9B	1.5B
Net Tangible Assets	3.0B	3.6B	4.1B	5.9B	6.8B	3.5B
Deferred Long Term Liab	113.6M	64.2M	95.5M	113.4M	130.4M	72.7M
Short Long Term Debt	1.2B	921.5M	530.6M	248.1M	144.6M	137.4M
Total Current Assets	3.5B	4.0B	3.9B	4.7B	4.2B	3.6B
Non Current Assets Total	2.0B	2.3B	2.7B	3.5B	3.9B	2.5B
Non Currrent Assets Other	7.0M	2.0M	2.8M	6.1M	3.7M	3.5M
Non Current Liabilities Total	349.8M	561.6M	712.0M	548.8M	387.2M	416.6M
Net Debt	752.1M	941.3M	639.2M	317.5M	285.7M	476.0M
Common Stock Shares Outstanding	557.7M	557.1M	556.5M	612.5M	704.3M	630.5M
Net Invested Capital	4.5B	5.0B	5.3B	6.8B	6.7B	5.6B
Net Working Capital	1.7B	2.2B	2.5B	3.6B	3.1B	2.6B
Capital Stock	557.7M	557.1M	556.5M	612.5M	704.3M	633.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Maccura Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Maccura Historical Balance Sheet

Maccura Biotechnology Inventory

775.14 Million

About Maccura Balance Sheet Analysis

Maccura Biotechnology Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Good Will

Maccura Biotechnology balance sheet Correlations

Maccura Biotechnology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Maccura Biotechnology balance sheet Accounts

Also Currently Popular

Other Information on Investing in Maccura Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant Equipment	+ 0.99	Total Assets
Total Liab	+ 0.99	Total Current Liabilities
Other Assets	+ 0.99	Other Liab
Inventory	+ 0.99	Net Receivables
Total Stockholder Equity	+ 0.98	Total Assets
Retained Earnings	+ 0.98	Total Assets

Non Currrent Assets Other	- 0.94	Short Term Debt
Non Currrent Assets Other	- 0.94	Net Receivables
Non Currrent Assets Other	- 0.93	Inventory
Non Currrent Assets Other	- 0.91	Total Liab
Non Currrent Assets Other	- 0.9	Other Current Assets
Non Currrent Assets Other	- 0.9	Total Current Liabilities